GlobeNewswire 3/2/2022 Harpoon Therapeutics Receives FDA Fast Track Designation for HPN217
GlobeNewswire 3/1/2022 Miromatrix Names Jim Douglas as New Chief Financial Officer
GlobeNewswire 3/1/2022 CytomX Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Busine...
GlobeNewswire 3/1/2022 Inventiva announces participation at several conferences in March 2022
GlobeNewswire 2/28/2022 Inventiva announces the schedule of publication and presentation of its 2021 Full-Year Financial Res...
GlobeNewswire 2/28/2022 CytomX Therapeutics to Present at Cowen 42nd Annual Healthcare Conference
GlobeNewswire 2/24/2022 Alector Reports Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire 2/24/2022 Morphic Announces Corporate Highlights and Financial Results for the Full Year 2021
GlobeNewswire 2/24/2022 SpringWorks Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Busi...
GlobeNewswire 2/22/2022 CytomX Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022
GlobeNewswire 2/22/2022 Morphic Presents Positive MORF-057 Data in Oral Presentation at ECCO 2022
GlobeNewswire 2/16/2022 Genmab Publishes 2021 Annual Report
GlobeNewswire 2/16/2022 Royalty Pharma Announces Inaugural Investor Day
GlobeNewswire 2/16/2022 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 2/15/2022 Coherus Names Paul Reider Chief Commercial Officer
GlobeNewswire 2/15/2022 Royalty Pharma Reports Q4 and Full Year 2021 Results
GlobeNewswire 2/14/2022 Inventiva reports cash position and revenues for Full-Year 2021
GlobeNewswire 2/10/2022 Sosei Heptares Operational Highlights and Consolidated Results for 12 Months ended 31 December 2021
GlobeNewswire 2/7/2022 Adverum Biotechnologies Appoints Richard Beckman M.D. as Chief Medical Officer
GlobeNewswire 2/2/2022 Bluejay Therapeutics Announces the Appointment of Nancy Shulman, M.D., as Chief Medical Officer
GlobeNewswire 2/1/2022 Dr. Maky Zanganeh Launches Personal Memoir, the Magic of Normal, to Honor February Cancer Survivor M...
GlobeNewswire 2/1/2022 The Fibroid Foundation Announces Fibroid Summit 2022 - a Patient-Hosted Research Conference
GlobeNewswire 1/31/2022 Inventiva receives a €4 million milestone payment from AbbVie for cedirogant Phase IIb initiation
GlobeNewswire 1/25/2022 Immunovant Appoints Mark Levine as Chief Legal Officer
GlobeNewswire 1/25/2022 Ocuphire to Host Virtual Investor R&D Day on January 31st